Secondary Hyperparathyroidism Treatment (SHPT) Market : Rising Cases Of Renal Disease Will Propel Growth

Secondary Hyperparathyroidism Treatment (SHPT) Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast latest study published by Fortune Business Insights. The increasing launch of effective drugs is a key factor driving the “U.S. Secondary Hyperparathyroidism Treatment Market” Size says Fortune Business Insights in a report, titled “Secondary Hyperparathyroidism Treatment (SHPT) Market” ,Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others) and Region Forecast, 2019-2026.” The secondary hyperparathyroidism treatment (SHPT) market was valued at USD 4.34 Billion in 2018 and is expected to reach USD 7.06 Billion by 2026, exhibiting a CAGR of 9.0%. As per the report the secondary hyperparathyroidism treatment market on the basis of drug class is segmented into calcimimetics, vitamin d analogues, and phosphate binders.

The calcimimetics segment is expected to hold maximum share during the forecast period owing to the numerous generic substitutes of Cinacalcet in the U.S. along with the rising demand for potent and specific therapy for the treatment of SHPT. For instance, according to a national survey conducted by American Journal of Kidney Diseases the use of Cinacalcet has increased from 23% to 31% between 2014 and 2017

The report provides a comprehensive assessment of the secondary hyperparathyroidism treatment market by inculcating valuable insights, facts, industry-related information, and historical data. Numerous approaches and methods are implemented to make meaningful assumptions and views. Furthermore, it offers a detailed analysis and information as per market segments, helping readers to get an inclusive overview of the market.

Request a Sample Copy of the Research Report: 

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664

This report focuses on Secondary Hyperparathyroidism Treatment (SHPT) Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.

Please Visit: https://www.fortunebusinessinsights.com/industry-reports/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664

Rising Prevalence Of Chronic Kidney Disease Will Stimulate Growth

The increasing prevalence of chronic kidney disease among geriatric population as well as general population will enable the growth of the secondary hyperparathyroidism treatment market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 15% of U.S adults, which, is, 37 million people are estimated to have chronic kidney disease. Additionally, CKD is found more common in people aged 65 years or older than in people aged 45-64 years. The rising cases of renal disease and increasing patient pool will have a significant impact on the market.  The increasing cost burden for the treatment of secondary hyperparathyroidism will further encourage growth of the market. In addition, the launch of generic form of Cinacalcet hydrochloride tablets will bode well for the secondary hyperparathyroidism treatment market. For instance, Cipla Inc. and its subsidiary Cipla USA Inc. announced the launch of a generic form of Cinacalcet hydrochloride tablets in USA. Moreover, Amgen Inc. announced the USFDA approval of Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD). The approval for Parsabiv will also aid the growth of the market during the forecast period.

Leading Players operating in the U.S Secondary Hyperparathyroidism Treatment Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Genzyme Corporation (Sanofi)
  • AbbVie Inc.
  • Cipla Inc.
  • Reddy’s Laboratories Ltd.
  • OPKO Health, Inc.
  • Other Prominent Players

Quick Buy –  U.S Secondary Hyperparathyroidism Treatment Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/101664

Reasons to Purchase this Report:

  • Comprehensive analysis of the U.S Secondary Hyperparathyroidism Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

KEY QUESTIONS ANSWERED:

  • What are the key technological and U.S Secondary Hyperparathyroidism Treatment Market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?
  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the U.S Secondary Hyperparathyroidism Treatment Market growth?

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664

Table of Content:

1 Secondary Hyperparathyroidism Treatment (SHPT) Market Overview

1.1 Secondary Hyperparathyroidism Treatment (SHPT) Product Overview

1.2 Secondary Hyperparathyroidism Treatment (SHPT) Market Segment by Type

1.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size by Type (2015-2027)

1.3.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size Overview by Type (2015-2027)

1.3.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Secondary Hyperparathyroidism Treatment (SHPT) Sales Breakdown by Type (2015-2027)

1.4.2 Europe Secondary Hyperparathyroidism Treatment (SHPT) Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Secondary Hyperparathyroidism Treatment (SHPT) Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Secondary Hyperparathyroidism Treatment (SHPT) Sales Breakdown by Type (2015-2027)

2 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Competition by Company

2.1 Global Top Players by Secondary Hyperparathyroidism Treatment (SHPT) Sales (2015-2021)

2.2 Global Top Players by Secondary Hyperparathyroidism Treatment (SHPT) Revenue (2015-2021)

2.3 Global Top Players Secondary Hyperparathyroidism Treatment (SHPT) Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Secondary Hyperparathyroidism Treatment (SHPT) Manufacturing Base Distribution, Sales Area, Product Type

2.5 Secondary Hyperparathyroidism Treatment (SHPT) Market Competitive Situation and Trends

2.5.1 Secondary Hyperparathyroidism Treatment (SHPT) Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Secondary Hyperparathyroidism Treatment (SHPT) Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Secondary Hyperparathyroidism Treatment (SHPT) as of 2019)

2.7 Date of Key Company Enter into Secondary Hyperparathyroidism Treatment (SHPT) Market

2.8 Key Company Secondary Hyperparathyroidism Treatment (SHPT) Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Secondary Hyperparathyroidism Treatment (SHPT) Status and Outlook by Region (2015-2027)

3.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size Market Share by Region (2015-2021)

3.2.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Region (2015-2021)

3.2.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Region (2015-2021)

3.2.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Market Size Market Share by Region (2021-2027)

3.3.1 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Region (2021-2027)

3.3.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Region (2021-2027)

3.3.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

3.4.1 North America Secondary Hyperparathyroidism Treatment (SHPT) Revenue By Growth (2015-2027)

3.4.2 North America Secondary Hyperparathyroidism Treatment (SHPT) Sales By Growth (2015-2027)

3.5 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Sales By Growth (2015-2027)

3.6 Europe Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

3.6.1 Europe Secondary Hyperparathyroidism Treatment (SHPT) Revenue By Growth (2015-2027)

3.6.2 Europe Secondary Hyperparathyroidism Treatment (SHPT) Sales By Growth (2015-2027)

3.7 Latin America Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

3.7.1 Latin America Secondary Hyperparathyroidism Treatment (SHPT) Revenue By Growth (2015-2027)

3.7.2 Latin America Secondary Hyperparathyroidism Treatment (SHPT) Sales By Growth (2015-2027)

3.8 Middle East and Africa Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Secondary Hyperparathyroidism Treatment (SHPT) Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Secondary Hyperparathyroidism Treatment (SHPT) Sales By Growth (2015-2027)

4 Global Secondary Hyperparathyroidism Treatment (SHPT) by Application

4.1 Secondary Hyperparathyroidism Treatment (SHPT) Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Secondary Hyperparathyroidism Treatment (SHPT) Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Secondary Hyperparathyroidism Treatment (SHPT) Historic Sales by Application (2015-2021)

4.4 Global Secondary Hyperparathyroidism Treatment (SHPT) Forecasted Sales by Application (2021-2027)

4.5 Key Regions Secondary Hyperparathyroidism Treatment (SHPT) Market Size by Application

4.5.1 North America Secondary Hyperparathyroidism Treatment (SHPT) by Application

4.5.2 Europe Secondary Hyperparathyroidism Treatment (SHPT) by Application

4.5.3 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) by Application

4.5.4 Latin America Secondary Hyperparathyroidism Treatment (SHPT) by Application

4.5.5 Middle East and Africa Secondary Hyperparathyroidism Treatment (SHPT) by Application

5 North America Secondary Hyperparathyroidism Treatment (SHPT) Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2015-2021)

5.1.2 North America Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2021-2027)

5.2.2 North America Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

5.3.2 Canada Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

6 Europe Secondary Hyperparathyroidism Treatment (SHPT) Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2015-2021)

6.1.2 Europe Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2021-2027)

6.2.2 Europe Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

6.3.2 France Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

6.3.3 U.K. Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

6.3.4 Italy Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

6.3.5 Russia Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Secondary Hyperparathyroidism Treatment (SHPT) Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.2 Japan Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.3 South Korea Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.4 India Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.5 Australia Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.6 Taiwan Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.7 Indonesia Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.8 Thailand Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.9 Malaysia Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

7.3.10 Philippines Secondary Hyperparathyroidism Treatment (SHPT) Market Size By Growth (2015-2027)

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs

 

Related Reports :

High Intensity Focused Ultrasound Market

High Intensity Focused Ultrasound Market Size

High Intensity Focused Ultrasound Market Share

High Intensity Focused Ultrasound Market Trends

High Intensity Focused Ultrasound Market Growth

High Intensity Focused Ultrasound Market Analysis

High Intensity Focused Ultrasound Market Business Opportunities

High Intensity Focused Ultrasound Market Key Players

High Intensity Focused Ultrasound Market Demand

High Intensity Focused Ultrasound Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *

Close